Skip to main content
. 2021 Sep 13;2(6):421–425. doi: 10.3168/jdsc.2021-0142

Figure 2.

Figure 2

13,14-Dihydro-15-keto-prostaglandin F (PGFM) and progesterone (P4) concentrations (pg/mL and ng/mL, respectively) for individual cows from −2 h to 24 h relative to subcutaneous treatment with dinoprost tromethamine (0 h; n = 6).